Open Access

Clinical case discussion: the value of optimising RAAS inhibition and preserving normokalemia in heart failure

Event: ESC Congress 2022
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session type: Satellite Symposium
Organised by PACE-CME - Supported by an unrestricted educational grant from AstraZeneca
Date: 27 August 2022
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Clinical case presentation of a patient with heart failure.

Speaker: Professor P. Van Der Meer (Groningen, NL)
Thumbnail

The importance of optimal RAASi therapy in heart failure.

Speaker: Professor D. Atar (Oslo, NO)
Thumbnail

How potassium binders can enable RAASi therapy in heart failure.

Speaker: Doctor M. Kosiborod (Kansas City, US)
Thumbnail

Practical guidance on use of potassium binders in the management of hyperkalemia in heart failure.

Speaker: Doctor C. Bonanad Lozano (Valencia, ES)
Thumbnail

Panel discussion.

Speaker: Professor P. Van Der Meer (Groningen, NL)
Thumbnail

5 speakers from this session

Professor Peter Van Der Meer

University Medical Centre Groningen, Groningen (Netherlands (The))
42 presentations
3 followers

Professor Dan Atar

Oslo University Hospital Rikshospitalet, Oslo (Norway)
11 presentations
0 follower

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
24 presentations
1 follower

Doctor Clara Bonanad Lozano

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)
2 presentations
0 follower

Professor Peter Van Der Meer

University Medical Centre Groningen, Groningen (Netherlands (The))
42 presentations
3 followers

This platform is supported by

logo Novo Nordisk